BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28912925)

  • 1. Incretin Kinetics Before and After Miglitol in Japanese Patients With Late Dumping Syndrome.
    Amagai M; Tsuchiya H; Chiba Y; Suzuki J; Nagakura J; Shigematsu E; Yamakawa T; Terauchi Y
    J Clin Med Res; 2017 Oct; 9(10):879-885. PubMed ID: 28912925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.
    Lee A; Patrick P; Wishart J; Horowitz M; Morley JE
    Diabetes Obes Metab; 2002 Sep; 4(5):329-35. PubMed ID: 12190996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome.
    Hasegawa T; Yoneda M; Nakamura K; Ohnishi K; Harada H; Kyouda T; Yoshida Y; Makino I
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1201-6. PubMed ID: 9918426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Miglitol, Acarbose, and Sitagliptin on Plasma Insulin and Gut Peptides in Type 2 Diabetes Mellitus: A Crossover Study.
    Ueno H; Tsuchimochi W; Wang HW; Yamashita E; Tsubouchi C; Nagamine K; Sakoda H; Nakazato M
    Diabetes Ther; 2015 Jun; 6(2):187-96. PubMed ID: 26055217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent Therapy with a Low-carbohydrate Diet and Miglitol Remarkably Improved the Postprandial Blood Glucose and Insulin Levels in a Patient with Reactive Hypoglycemia due to Late Dumping Syndrome.
    Hirose S; Iwahashi Y; Seo A; Sumiyoshi M; Takahashi T; Tamori Y
    Intern Med; 2016; 55(9):1137-42. PubMed ID: 27150868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of miglitol, sitagliptin or their combination on plasma glucose, insulin and incretin levels in non-diabetic men.
    Aoki K; Masuda K; Miyazaki T; Togashi Y; Terauchi Y
    Endocr J; 2010; 57(8):667-72. PubMed ID: 20519806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide improves early dumping syndrome potentially through incretins: a case report.
    Sato D; Morino K; Ohashi N; Ueda E; Ikeda K; Yamamoto H; Ugi S; Yamamoto H; Araki S; Maegawa H
    Endocr J; 2013; 60(7):847-53. PubMed ID: 23708181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incretin effects, gastric emptying and insulin responses to low oral glucose loads in patients after gastric bypass and lean and obese controls.
    Wölnerhanssen BK; Meyer-Gerspach AC; Peters T; Beglinger C; Peterli R
    Surg Obes Relat Dis; 2016 Aug; 12(7):1320-1327. PubMed ID: 27012873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pre-meal versus post-meal administration of miglitol on plasma glucagon-like peptide-1 and glucosedependent insulinotropic polypeptide levels in healthy men.
    Aoki K; Miyazaki T; Nagakura J; Orime K; Togashi Y; Terauchi Y
    Endocr J; 2010; 57(8):673-7. PubMed ID: 20519807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single administration of alpha-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease - Juntendo University trial: effects of miglitol on endothelial vascular reactivity in type 2 diabetic patients with coronary heart disease (J-MACH) -.
    Hiki M; Shimada K; Kiyanagi T; Fukao K; Hirose K; Ohsaka H; Fukushima Y; Kume A; Matsumori R; Sumiyoshi K; Miyazaki T; Ohmura H; Kurata T; Miida T; Daida H
    Circ J; 2010 Jul; 74(7):1471-8. PubMed ID: 20519875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of miglitol taken just before or after breakfast on plasma glucose, serum insulin, glucagon and incretin levels after lunch in men with normal glucose tolerance, impaired fasting glucose or impaired glucose tolerance.
    Masuda K; Aoki K; Terauchi Y
    J Diabetes Investig; 2011 Nov; 2(6):435-40. PubMed ID: 24843527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy.
    Miholic J; Orskov C; Holst JJ; Kotzerke J; Meyer HJ
    Dig Dis Sci; 1991 Oct; 36(10):1361-70. PubMed ID: 1914756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin.
    Aoki K; Kamiyama H; Yoshimura K; Shibuya M; Masuda K; Terauchi Y
    Acta Diabetol; 2012 Jun; 49(3):225-30. PubMed ID: 21898126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incretin system and its role in type 2 diabetes mellitus.
    Holst JJ; Vilsbøll T; Deacon CF
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):127-36. PubMed ID: 18786605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible difference in the mechanism for postprandial hypoglycemia associated with dumping syndrome between patients with and without type 2 diabetes.
    Hamasaki H; Moriyama S; Yanai H
    Obes Res Clin Pract; 2015; 9(6):622-4. PubMed ID: 26321136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects.
    Arakawa M; Ebato C; Mita T; Fujitani Y; Shimizu T; Watada H; Kawamori R; Hirose T
    Metabolism; 2008 Sep; 57(9):1299-306. PubMed ID: 18702958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
    Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia.
    Toft-Nielsen M; Madsbad S; Holst JJ
    Diabetologia; 1998 Oct; 41(10):1180-6. PubMed ID: 9794105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Miglitol (Bay m1099), a new alpha-glucosidase inhibitor, on glucose, insulin, C-peptide and GIP responses to an oral sucrose load in patients with post-prandial hypoglycaemic symptoms.
    Renard E; Parer-Richard C; Richard JL; Jureidini S; Orsetti A; Mirouze J
    Diabete Metab; 1991; 17(3):355-62. PubMed ID: 1884880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.